ClinicalTrialsFinder

Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID) Clinical Trials in Shenzhen, Guangdong

1 recruitingShenzhen, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)

Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)
Shenzhen Geno-Immune Medical Institute10 enrolled2 locationsNCT03645460